Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$883M |
| 2 |
Boeing
BA
|
$345M |
| 3 |
Salesforce
CRM
|
$344M |
| 4 |
DexCom
DXCM
|
$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
$779M |
| 2 |
Chevron
CVX
|
$585M |
| 3 |
Home Depot
HD
|
$264M |
| 4 |
Chubb
CB
|
$263M |
| 5 |
PepsiCo
PEP
|
$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.63% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Popular Inc
BPOP
$8.47B
| $97.6M | 0.05% |
1,471,368
+846,247
| +135% | +$56.1M |
|
227
Okta
OKTA
$16.1B
| $97.3M | 0.05% |
1,424,099
+536,829
| +61% | +$36.7M |
|
228
Vertex Pharmaceuticals
VRTX
$102B
| $97.2M | 0.05% |
336,562
+333,024
| +9,413% | +$96.2M |
|
229
Synopsys
SNPS
$111B
| $97M | 0.05% |
303,724
+178,732
| +143% | +$57.1M |
|
|
COUP
230
DELISTED
Coupa Software Incorporated
COUP
| $96.4M | 0.05% |
1,218,163
+514,919
| +73% | +$40.8M |
|
231
Lockheed Martin
LMT
$108B
| $96M | 0.05% |
197,422
+174,648
| +767% | +$85M |
|
232
Revvity
RVTY
$10.1B
| $95.8M | 0.05% |
683,318
+640,504
| +1,496% | +$89.8M |
|
233
Medpace
MEDP
$13.7B
| $95.8M | 0.05% |
450,938
+243,001
| +117% | +$51.6M |
|
234
Interactive Brokers
IBKR
$26.8B
| $95.6M | 0.05% |
5,287,896
-2,654,392
| -33% | -$48M |
|
235
Charles River Laboratories
CRL
$8.07B
| $95.4M | 0.05% |
+437,787
| New | +$95.4M |
|
236
Schlumberger
SLB
$53.4B
| $95.4M | 0.05% |
1,783,890
+1,078,532
| +153% | +$57.7M |
|
237
Verisk Analytics
VRSK
$37.8B
| $94.7M | 0.05% |
537,047
+461,634
| +612% | +$81.4M |
|
238
Truist Financial
TFC
$60B
| $94.5M | 0.05% |
2,196,963
+2,180,845
| +13,530% | +$93.8M |
|
239
Archer Daniels Midland
ADM
$30.2B
| $94.5M | 0.05% |
1,017,907
+264,391
| +35% | +$24.5M |
|
240
CBRE Group
CBRE
$48.9B
| $94.4M | 0.05% |
1,226,356
-193,708
| -14% | -$14.9M |
|
241
Guidewire Software
GWRE
$22B
| $94.3M | 0.05% |
1,506,620
+1,097,453
| +268% | +$68.7M |
|
242
Biogen
BIIB
$20.6B
| $93.8M | 0.05% |
338,585
-574,120
| -63% | -$159M |
|
243
MSCI
MSCI
$42.9B
| $93.4M | 0.05% |
200,681
+124,025
| +162% | +$57.7M |
|
244
Boyd Gaming
BYD
$6.93B
| $93.3M | 0.05% |
1,711,767
+847,797
| +98% | +$46.2M |
|
245
Universal Health Services
UHS
$12.1B
| $93M | 0.05% |
660,250
+563,139
| +580% | +$79.3M |
|
246
F5
FFIV
$18.1B
| $92.3M | 0.05% |
643,449
+549,127
| +582% | +$78.8M |
|
247
Marriott International Class A Common Stock
MAR
$71.9B
| $92M | 0.05% |
618,044
+524,838
| +563% | +$78.1M |
|
248
HCA Healthcare
HCA
$98.5B
| $91.8M | 0.05% |
382,737
-316,289
| -45% | -$75.9M |
|
249
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $91.6M | 0.05% |
709,181
-432,664
| -38% | -$55.9M |
|
250
Micron Technology
MU
$147B
| $91.4M | 0.05% |
1,829,406
+141,850
| +8% | +$7.09M |
|